Dana Leblanc
Pediatric Hematology-Oncology · New Orleans, LANPI 1164666723
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (37.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Pfizer at 38.3% of the total. 2025 is the largest year on record at $7,759, more than ten times the $738 reported in 2019.
Across 159 payments — averaging $156.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$10K
- Global Blood Therapeutics, Inc.$7K
- Novartis$5K
- Genetix Biotherapeutics Inc$864
- Jazz Pharmaceuticals Inc.$250
- Novo Nordisk$248
- plus $2K from 26 others
Across 4 payments — averaging $3315.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$8K
- Global Blood Therapeutics, Inc.$3K
- Pfizer$3K
What the payments were for
- Consulting fees$8,35733%
- Speaking & faculty fees$9,39038%
- Travel & lodging$1,5296%
- Food & beverage$5,57322%
- Education$980%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 13 | $9,562 |
| Global Blood Therapeutics, Inc. | 12 | $6,748 |
| Novartis | 37 | $5,140 |
| Genetix Biotherapeutics Inc | 11 | $864 |
| Jazz Pharmaceuticals Inc. | 4 | $250 |
| Novo Nordisk | 12 | $248 |
| Sobi, Inc | 8 | $234 |
| Servier Pharmaceuticals LLC | 13 | $228 |
| BTG International Inc. | 4 | $227 |
| AstraZeneca(2 entities) | 9 | $176 |
| CSL Behring | 6 | $141 |
| Seagen Inc. | 3 | $140 |
| Incyte Corporation | 1 | $125 |
| Bioverativ Therapeutics Inc. | 1 | $110 |
| Octapharma USA, Inc. | 4 | $104 |
| Terumo BCT, Inc. | 1 | $103 |
| EMD Serono, Inc. | 1 | $100 |
| Vertex | 2 | $79 |
| Bayer | 3 | $66 |
| Eurofins Viracor, LLC | 1 | $36 |
| Springworks Therapeutics, Inc. | 1 | $33 |
| Y-mabs Therapeutics, Inc. | 1 | $31 |
| Fennec Pharmaceuticals, Inc. | 1 | $28 |
| Medunik USA Inc. | 1 | $25 |
| Emmaus Medical, Inc. | 2 | $23 |
| USWM, LLC | 1 | $22 |
| Epizyme, Inc. | 1 | $21 |
| Genentech USA, Inc. | 1 | $21 |
| Chiesi USA, Inc. | 1 | $19 |
| Shire North American Group Inc | 1 | $17 |
| Amgen | 1 | $15 |
| Silvergate Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$24,947 in reported general payments places this provider in the 80th percentile of 26 pediatric hematology-oncology providers in Louisiana.
See all pediatric hematology-oncology providers in Louisiana →
Other pediatric hematology-oncology in New Orleans
- Tammuella Chrisentery-SingletonNew Orleans$1.4M
- Maria Velez-YanguasNew Orleans$105K
- Zachary LeblancNew Orleans$55K
- Renee GardnerNew Orleans$25K
- Pinki PrasadNew Orleans$20K
- Robert VasquezNew Orleans$6K
- Lolie YuNew Orleans$3K
- Craig LottermanNew Orleans$3K
- Cori MorrisonNew Orleans$1K
- Justin FargeNew Orleans$797
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.